Stock data

神隆 (1789)

神隆 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$309.44M, up 74.4% from a year earlier. EPS over the last four quarters totals NT$0.05.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 神隆 in Insightr